Status:
COMPLETED
Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool
Lead Sponsor:
Bayer
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
In this study researchers want to gain more information on patients who are treated with Metformin for their Type 2 Diabetes. Adult female and male patients with a prescription of a Metformin containi...
Eligibility Criteria
Inclusion
- Adult female or male patient
- Valid prescription for a Metformin containing drug approved in Germany
- Decision to initiate treatment with Metformin was made by the treating physician as part of the routine treatment practice
- Signed informed consent
Exclusion
- \- Not applicable
Key Trial Info
Start Date :
July 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 27 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04383041
Start Date
July 2 2020
End Date
January 27 2021
Last Update
July 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many locations
Multiple Locations, Germany